From: Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia
 | KFRE equations | Brier scorea (square root) | Biasa (95% CI) | Precisiona |
---|---|---|---|---|
5-year risk | ||||
 Existing KFRE equations | Original KFRE [17] | 6.2% | 4.5% (− 1.4–5.9%) | 4.3% |
Original KFRE calibrated for north American [17] | 4.8% | 4.1% (0.2–5.8%) | 2.6% | |
Original KFRE calibrated for non-north American [17] | 7.2% | 4.8% (− 2.8–7.6%) | 4.3% | |
Pooled KFRE [17] | 4.0% | 3.3% (− 0.1–6.7%) | 1.7% | |
 Recalibrated KFRE equations | Recalibrated Original KFRE SEA 1b | 9.3% | 5.1% (− 6.9–12.0%) | 5.1% |
Recalibrated Original KFRE SEA 2c | 7.9% | 5.2% (−4.4–9.6%) | 5.2% | |
Recalibrated Pooled KFRE SEAd | 2.8% | 2.5% (−2.0–4.5%) | 0.5% | |
2-year risk | ||||
 Existing KFRE equations | Original KFRE [17] | 7.9% | 3.4% (−7.8–11.2%) | 3.8% |
Original KFRE calibrated for north American [17] | 7.9% | 3.4% (− 7.8–11.2%) | 3.8% | |
Original KFRE calibrated for non-north American [17] | 9.1% | 3.5% (−10.4%-13.95) | 4.2% | |
Pooled KFRE [17] | 7.9% | 3.2% (−8.7–11.9%) | 3.5% | |
 Recalibrated KFRE equations | Recalibrated Original KFRE SEA 1e | 9.0% | 3.5% (−10.0–13.5%) | 4.1% |
Recalibrated Original KFRE SEA 2f | 6.1% | 3.6% (−5.1–8.7%) | 3.9% | |
Recalibrated Pooled KFRE SEAg | 2.0% | 1.8% (−1.7–3.5%) | 0.5% |